Researchers at the USC Leonard Davis School of Gerontology have discovered a genetic mutation in a small mitochondrial protein that may promote longevity, preserve cognitive function, and protect against Alzheimer's disease among carriers of APOE4, a gene associated with a dramatic increase in the risk of developing Alzheimer's disease.
Newly discovered beneficial mutation in mitochondrial DNA seems to help Alzheimer's gene carriers live longer retrieved 25 March 2024 from https://medicalxpress.com/news/2024-03-newly-beneficial-mutation-mitochondrial-dna.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.4 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Researchers identify mutation that alters Alzheimer's disease progressionThe scientist of the Faculty of Medicine of the University of Malaga José Luis Royo has coordinated a study that summarizes eight years of research and brings together 100 multidisciplinary specialists, identifying a mutation that alters Alzheimer's disease progression.
続きを読む »
Researchers identify novel genetic variants associated with Alzheimer's diseaseIdentifying genetic variants and the role they play in predisposing people to Alzheimer's disease can help researchers better understand how to treat the neurodegenerative condition for which there is currently no cure.
続きを読む »
Class of Alzheimer's drug presents unique challenge for patients with cardiovascular diseaseA new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled ' Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty,' advocates for additional research to improve decision making prior to initiating lecanemab, commercially known as Leqembi, an FDA-approved Alzheimer's...
続きを読む »
Researchers report rise in global fungal drug-resistant infectionsA global wave of infections caused by fungi growing drug-resistant has the medical community issuing precautions on how to protect yourself.
続きを読む »
Researchers use algorithm to provide innovative insights into the heterogeneity of type 2 diabetesA landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize the metabolic diversity of diabetes.
続きを読む »
Erection pills like Viagra linked to more than 200 deaths in Britain – from brain bleeds to heart attacks...Viagra slashes men’s risk of Alzheimer’s disease
続きを読む »